GSK shelves cough drug acquired in $2B deal
London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
Knowledge and News for the Global Fight Against Cancer.
London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
At the prestigious 2026 AACR Annual Meeting, held as a pivotal gathering for the global...
The biopharmaceutical industry finds itself navigating a complex legal and scientific terrain this week, marked...
The sun went down hours ago, casting the world outside into shadow, yet inside a...
In a pivotal move to reverse its flagging fortunes, Jasper Therapeutics, a biotechnology company that...
In a pivotal move to safeguard the future of cancer research, the Cancer Research Institute...
The U.S. Food and Drug Administration (FDA) has granted approval to Lipfendra, a groundbreaking new...
In a world often consumed by the extraordinary, the stories of Sharon Belvin and Jenney...
Boston, MA – Veradermics, a burgeoning biopharmaceutical firm, has announced groundbreaking results from its Phase...
From May 16 to 22, 2026, the La Cantera Resort in San Antonio, Texas, became...